Investment analysis, share recommendations, and market insights.
Last week, three of the major banks reported full year profit results (CBA will provide a third quarter trading update on Wednesday). Here’s a review of what we learnt and my position in relation to the question about how to play the banks going forward.
“Macquarie (MQG) financial year 2025 net profit after tax (NPAT) of $3.7 billion was +1% above Factset consensus (A$3.7 billion),” Raymond said. “Overall, we saw […]
Here are two micro-cap companies that ply their trade in industries where both regulation and the search for economic efficiency is pushing participants toward the solutions they offer. Patient investors could be well-rewarded in the long run.
Here are two undervalued listed property trusts that own childcare centres.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why Regis Healthcare (REG) is currently a buying opportunity.
I’ve been looking for recommendations for two of my financial planning clients. I’ll share with you what I’ve come up with. Be clear on this: if they were full-on growth investors, then I’d be more aggressive.
In a very volatile April, our model portfolios finished higher. Our income portfolio continues to outperform.
In our “HOT” stock column today, Raymond Chan, Head of Asian Desk at Morgans, explains that Morgans sees Iress Limited (IRE) providing investors a decent upside ‘option’.
Here’s a look at four ASX companies that say they’re global leaders, and are hoping to be the next WiseTech, replicating what it has done in the global logistics industry.
The big miners have fallen too far, and I see reasonable value for the first time in a long time. Prospective investors can buy stocks directly (and I’ll tell you my preferences), though as you’d expect, I do like resource-sector ETFs for more diversified exposure.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.